Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-20-084530
Filing Date
2020-07-17
Accepted
2020-07-17 16:26:48
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-1 tm2024930-1_f1.htm F-1 565428
2 EXHIBIT 5.1 tm2024930d1_ex5-1.htm EX-5.1 37166
3 EXHIBIT 23.1 tm2024930d1_ex23-1.htm EX-23.1 4403
4 GRAPHIC image_002.jpg GRAPHIC 3370
5 GRAPHIC image_003.jpg GRAPHIC 3358
6 GRAPHIC image_001.jpg GRAPHIC 1928
  Complete submission text file 0001104659-20-084530.txt   620504
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1 | Act: 33 | File No.: 333-239923 | Film No.: 201034032
SIC: 2834 Pharmaceutical Preparations